Eric Lefkofsky And Tempus Create Data Precision Operating Systems To Battle Cancer

by GSR2016 .

Every year, thousands of people lose the battle to cancer and leave their loved ones behind to go through immense grief and pain. A few years ago, Eric Lefkofsky, helped his wife win the battle against breast cancer, and although they were triumphant, this made the couple realize the gap between available patient information versus the actual usable data that can be used to create compelling treatment plans. This realization gave birth to Tempus, an initiative by Eric Lefkofsky that uses data precision devices to compute large chunks of data and make it usable to formulate patient-specific treatment plans.

Eric Lefkofsky faced various challenges when he conceptualized data precision devices, better known as the operating system that can battle cancer. The first of these obstacles was to get access to patient data, and when this barrier was crossed, the next challenge was to make sense of written and typed doctor’s notes as well as other significant chunks of patient data. This situation was remedied by including natural language processing and optical character recognition capabilities as part of the data precision devices. This power moved allowed text fields to be captured, digitally inputted and analyzed accurately. The result of this entire process was to be able to read free text fields, with critical notes and transform all these pieces of data into structured and usable information

Tempus is powered primarily by Eric Lefkofsky and his core team and is supported by his wife who understands the importance of the need for this technology. The data precision devices gather molecular data as well as other information, compute and transform seemingly random doctor’s assessments into an actual treatment plan that is designed keeping the nature and intensity of the ailment in mind.

Together with the love and support of his wife, Eric Lefkofsky established the Lefkofsky Family Foundation. This private charitable fund, aids in the attempts to advance high-impact techniques to improve the lives of various social groups and communities. Eric Lefkofsky also acts as a Trustee in various organizations in and around Chicago. One of these medical organizations includes the Lurie Children’s Hospital.

SahmAdrangi transforms Kerrisdale Capital Management

by GSR2016 .

SahmAdrangi an entrepreneur, an activist and the founder of Kerrisdale Capital Management Firm. He founded the firm in 2009 and currently holds a position as the Chief Investment Officer where he has been involved practically in every development of the company to date. The starting capital of the firm was 1 million dollars which have grown over the years to over 150 million dollars in management as of July 2017. The influential hedge fund manager started his financial career at Deutsche Bank in the credit section. He also worked with Chanin Capital Partners as an advisor of the creditor committee on matters of bankruptcy and out-of-court restructuring situations.

SahmAdrangi attended Yale University and graduated with a Bachelor’s of Arts in Economics. He has been invited to give speeches on different conferences including the Distressed Debt Investing Conference, the Sohn Conference, the Traders for a cause, the value investing conference as well as the Activists Investor Conferences among many others. SahmAdrangi has been invited for interviews on Bloomberg and CNBC as well as featured in prestigious publications including New York Times, BusinessWeek, the Washington Post and The Wall Street Journal.

The primary objective of Kerrisdale Capital is to educate the general public about companies and organisations through publishing and sharing insight on a particular company research online to clear any misunderstandings that the public may have. Kerrisdale capital has published a lot of research on different companies in different sectors. Recently the organisation is focused on the biotechnology sector with the organisation publishing research on the developmental and progressive stages of firms in the industry including Zafgen, Sage Therapeutics and Pulse Biosciences.

The telecommunications sector has become another area of expertise by the Kerrisdale Group. The corporation has shared its views and insights on companies such as ViaSat Inc., Straight Path Communications, Dish Network and Globalstar. SahmAdrangi exposed the weaknesses of a proposal by Globalstar the Terrestrial Low Power Services in a live presentation and several publications. Kerrisdale has also taken a keen interest in the mining sector with a focus mainly on the mining prospects and market valuation of the Northern Dynasty Minerals and the First Majestic Silver and numerous other companies in that industry.